The Prevalence and Phenotypic Manifestations of Polycystic Ovary Syndrome (PCOS) Among Infertile Sudanese Women: a Cross-sectional Study

Overview

Journal BMC Womens Health

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2022 May 13

PMID 35562723

Authors

Alawia N Elasam

Mohamed A Ahmed

Abdel B A Ahmed

Manal E Sharif

Abdalla Abusham

Bahaeldin Hassan

Ishag Adam

Affiliations

Soon will be listed here.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a global health problem associated with significant morbidity during reproductive age. Only a few published studies that address the clinical manifestations and phenotypic presentation of the disease have been conducted in Africa, including Sudan. Thus, this study aimed to evaluate the clinical and biochemical presentation of the different PCOS phenotypes among infertile Sudanese women.

Methods: A cross-sectional, descriptive study was conducted from January to December 2019. A total of 368 infertile women with PCOS (based on the Rotterdam criteria) were recruited from a fertility center in Khartoum, Sudan. Clinical, hormonal, and ultrasonographic characteristics were described and compared between the four phenotypes of PCOS.

Results: Majority (321 [87.2%]) of the women had oligo/anovulation (OA). Polycystic ovary morphology on ultrasound appeared in 236 (64.1%) women, acne in 171 (46.5%) women, acanthosis nigricans in 81 (22.0%) women, and hirsutism in 101 (27.4%) women. Phenotype D was the most prevalent among infertile Sudanese women (51.6%), followed by phenotype B (22.6%), phenotype C (18.2%), and phenotype A (7.6%). No statistical differences in the body mass index and hormonal profile between the four phenotypes were noted. Women with phenotype A were older and had high mean blood pressure, and a higher waist/hip ratio was observed among women with phenotype D.

Conclusion: Unlike the global distribution of PCOS phenotypes, Sudanese women uniquely expressed phenotype D as the most prevalent. More epidemiological studies are needed in the region due to geographical, ethnic, and genetic variations.

Citing Articles

The therapeutic effects of curcumin on polycystic ovary syndrome by upregulating PPAR-γ expression and reducing oxidative stress in a rat model.

Zhang W, Peng C, Xu L, Zhao Y, Huang C, Lu L Front Endocrinol (Lausanne). 2024; 15:1494852.

PMID: 39634175 PMC: 11614657. DOI: 10.3389/fendo.2024.1494852.

Predicting Unfavorable Pregnancy Outcomes in Polycystic Ovary Syndrome (PCOS) Patients Using Machine Learning Algorithms.

Mogos R, Gheorghe L, Carauleanu A, Vasilache I, Munteanu I, Mogos S Medicina (Kaunas). 2024; 60(8).

PMID: 39202579 PMC: 11356493. DOI: 10.3390/medicina60081298.

Lower Serum ATG7 Levels Linked to Insulin Resistance in Women with Polycystic Ovary Syndrome.

Lu L, Wu B, Peng C, Zhang W, Zhao Y, Huang C Med Sci Monit. 2024; 30:e944556.

PMID: 39161055 PMC: 11344473. DOI: 10.12659/MSM.944556.

Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study.

Singh S, Kaur M, Beri A, Kaur A Sci Rep. 2023; 13(1):22841.

PMID: 38129424 PMC: 10739822. DOI: 10.1038/s41598-023-48881-0.

Polycystic Ovary Syndrome: A Literature Review With a Focus on Diagnosis, Pathophysiology, and Management.

Waghmare S, Shanoo A Cureus. 2023; 15(10):e47408.

PMID: 38021970 PMC: 10657909. DOI: 10.7759/cureus.47408.

References

Pembe A, Abeid M . Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania. Tanzan J Health Res. 2010; 11(4):175-80. DOI: 10.4314/thrb.v11i4.50172. View

Tay C, Hart R, Hickey M, Moran L, Earnest A, Doherty D . Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020; 18(1):389. PMC: 7731536. DOI: 10.1186/s12916-020-01861-x. View

Paul C, Lagana A, Maniglio P, Triolo O, Brady D . Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecol Endocrinol. 2016; 32(6):431-8. DOI: 10.3109/09513590.2016.1144741. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

Wild R, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale H, Futterweit W . Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010; 95(5):2038-49. DOI: 10.1210/jc.2009-2724. View

Azziz R . Polycystic Ovary Syndrome. Obstet Gynecol. 2018; 132(2):321-336. DOI: 10.1097/AOG.0000000000002698. View

Luque-Ramirez M, Escobar-Morreale H . Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity. Curr Hypertens Rep. 2014; 16(12):500. DOI: 10.1007/s11906-014-0500-6. View

Lizneva D, Kirubakaran R, Mykhalchenko K, Suturina L, Chernukha G, Diamond M . Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis. Fertil Steril. 2016; 106(6):1510-1520.e2. DOI: 10.1016/j.fertnstert.2016.07.1121. View

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007; 45(4):247-51. DOI: 10.1016/j.ypmed.2007.08.012. View

10.

Zhang H, Zhu F, Xiong J, Shi X, Fu S . Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG. 2009; 116(12):1633-9. DOI: 10.1111/j.1471-0528.2009.02347.x. View

11.

Li R, Zhang Q, Yang D, Li S, Lu S, Wu X . Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013; 28(9):2562-9. DOI: 10.1093/humrep/det262. View

12.

Al-Jefout M, Alnawaiseh N, Al-Qtaitat A . Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Sci Rep. 2017; 7(1):5339. PMC: 5509707. DOI: 10.1038/s41598-017-05717-y. View

13.

Jamil A, Alalaf S, Al-Tawil N, Al-Shawaf T . Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch Gynecol Obstet. 2015; 293(2):447-56. DOI: 10.1007/s00404-015-3889-5. View

14.

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2008; 91(2):456-88. DOI: 10.1016/j.fertnstert.2008.06.035. View

15.

Ota E, Haruna M, Suzuki M, Anh D, Tho L, Tam N . Maternal body mass index and gestational weight gain and their association with perinatal outcomes in Viet Nam. Bull World Health Organ. 2011; 89(2):127-36. PMC: 3040376. DOI: 10.2471/BLT.10.077982. View

16.

Ntumy M, Maya E, Lizneva D, Adanu R, Azziz R . The pressing need for standardization in epidemiologic studies of PCOS across the globe. Gynecol Endocrinol. 2019; 35(1):1-3. DOI: 10.1080/09513590.2018.1488958. View

17.

Ezeh U, Yildiz B, Azziz R . Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2013; 98(6):E1088-96. PMC: 3667270. DOI: 10.1210/jc.2013-1295. View

18.

Hallajzadeh J, Khoramdad M, Karamzad N, Almasi-Hashiani A, Janati A, Ayubi E . Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis. J Cardiovasc Thorac Res. 2018; 10(2):56-69. PMC: 6088762. DOI: 10.15171/jcvtr.2018.10. View

19.

Facchinetti F, Espinola M, Dewailly D, Ozay A, Prapas N, Vazquez-Levin M . Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART). Trends Endocrinol Metab. 2020; 31(8):570-579. DOI: 10.1016/j.tem.2020.04.003. View

20.

de Medeiros S, Yamamoto M, de Medeiros M, Barbosa B, Soares J, Baracat E . Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age. Endocr Connect. 2020; 9(2):74-89. PMC: 6993261. DOI: 10.1530/EC-19-0496. View